Complete XLO Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
XLO Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 7 peer companies in Healthcare
P/E Ratio
$0.00
-100.0%
Peer Median: 0.0x
EV/EBITDA
$0.00
-100.0%
Peer Median: 0.0x
P/S Ratio
$1.39
+99.8%
Peer Median: 7.7x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for XLO's business model and current situation.
Multiple Comparison
| Multiple | XLO Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -1.3x | 0.0x | 0.0x | -Infinity% | Undervalued |
| EV/EBITDA | -Infinityx | 0.0x | 0.0x | -Infinity% | Undervalued |
| P/S Ratio | 3.9x | 7.7x | 6.5x | -49.9% | Undervalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.05B | 0.0x | 0.0x | 13.2x | |
| $0.05B | 0.0x | 0.0x | 0.0x | |
| $0.05B | 0.0x | 0.0x | 0.0x | |
| $0.04B | 0.0x | 0.0x | 3.9x | |
| $0.05B | 0.0x | 0.0x | 214.1x | |
| $0.05B | 0.0x | 0.0x | 7.7x | |
| $0.05B | 0.0x | 0.0x | 1.4x |